Table 2.
Total (N = 189) | Non-critically ill (N = 162) | Critically ill (N = 27) | p value | |
---|---|---|---|---|
Findings | ||||
GGO | 50 (26.5 %) | 48 (29.6 %) | 2 (7.4 %) | 0.023 |
Consolidation | 17 (9.0 %) | 15 (9.3 %) | 2 (7.4 %) | 0.78 |
GGO + consolidation | 113 (59.8 %) | 90 (55.6 %) | 23 (85.2 %) | 0.008 |
Halo sign | 3 (1.6 %) | 3 (1.9 %) | – | 0.477 |
Crazy paving | 96 (50.8 %) | 72 (44.4 %) | 24 (88.9 %) | <0.0001 |
Bronchial wall thickening | 154 (81.5 %) | 129 (79.6 %) | 25 (92.6 %) | 0.134 |
Air bronchogram | 88 (46.6 %) | 69 (42.6 %) | 19 (70.4 %) | 0.018 |
Bronchial distortion | 41 (21.7 %) | 30 (18.5 %) | 11 (40.7 %) | 0.031 |
Linear opacities | 89 (47.1 %) | 76 (469%) | 13 (49.7 %) | 0.243 |
Vascular enlargement | 34 (18.0 %) | 24 (14.8 %) | 10 (37.0 %) | 0.023 |
Distribution | ||||
Central | 6 (3.17 %) | 6 (3.7 %) | – | 0.311 |
Peripheral | 135 (71.4 %) | 123 (75.9 %) | 12 (44.4 %) | 0.005 |
Central + peripheral | 42 (22.2 %) | 27 (16.7 %) | 15 (55.6 %) | <0.0001 |
Lymph node involvement | 44 (23.3 %) | 30 (18.5 %) | 14 (51.9 %) | 0.002 |
GGO = ground glass opacities.